In the case of the conventional αβ T cell platform, multiplex gene editing is essential to disrupt the native αβ TCR, involving the disruption of TRAC and/or TRBC loci, to prevent GvHD induced by HLA incompatibility4. The gene discussed is TRAC; the disease is graft versus host disease.